Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 335.48%13.65M | -43.72%18.29M | -94.46%2.24M | 139.85%54.65M | -224.92%-21.44M | 105.91%3.13M | 542.22%32.49M | 253.38%40.46M | -66.22%22.78M | -41.02%17.16M |
| Net income from continuing operations | 99.73%-974K | 164.11%13.03M | -32.03%5.25M | -772.39%-357.85M | 73.44%-3.39M | -3,785.24%-367.12M | 85.95%4.94M | 135.95%7.72M | -258.12%-41.02M | -190.20%-12.75M |
| Operating gains losses | -100.37%-1.74M | -424.96%-14.86M | -111.22%-14.2M | 983.03%466.07M | -158.59%-8.25M | 3,836.77%476.47M | 137.67%4.57M | -123.19%-6.72M | 831.25%43.03M | 203.61%14.07M |
| Depreciation and amortization | 0.78%5.65M | -58.46%3.88M | -58.80%3.94M | 22.92%31.45M | -26.56%6.94M | -5.63%5.61M | 77.32%9.33M | 94.23%9.56M | 31.60%25.59M | 86.76%9.45M |
| Asset impairment expenditure | --0 | ---- | ---- | --801K | --0 | --801K | ---- | ---- | --0 | --0 |
| Unrealized gains and losses of investment securities | --0 | --0 | --0 | --2.09M | --0 | --4.44M | --0 | ---2.35M | --0 | --0 |
| Remuneration paid in stock | -84.57%71K | 172.19%431K | -99.76%2K | -128.15%-1.13M | -376.83%-1.82M | -1.08%460K | -147.95%-597K | -50.39%821K | 91.93%4.02M | -7.34%656K |
| Deferred tax | --0 | --0 | --0 | -406.34%-115.62M | 94.41%-714K | -3,297.57%-118.75M | 40.90%1.56M | 129.81%2.28M | -329.12%-22.83M | -313.67%-12.78M |
| Other non cashItems | -40.62%5.62M | -41.78%5.68M | -50.00%5.41M | 69.81%37.07M | 27.26%7.02M | 57.06%9.47M | 75.66%9.76M | 128.83%10.82M | 204.45%21.83M | 69.30%5.51M |
| Change In working capital | 160.74%5.02M | 245.29%10.12M | -89.93%1.85M | -5.18%-8.24M | -263.46%-21.24M | 18.07%-8.26M | 126.55%2.93M | 6,262.15%18.32M | -189.91%-7.83M | -4.03%12.99M |
| -Change in receivables | ---- | ---- | ---- | -212.30%-9.7M | ---- | ---- | ---- | -315.96%-7.92M | -199.62%-3.11M | ---- |
| -Change in inventory | ---- | ---- | ---- | 106.14%2.61M | ---- | ---- | ---- | 852.87%3.67M | -3,778.98%-42.44M | ---- |
| -Change in prepaid assets | ---- | ---- | ---- | 162.62%4.95M | ---- | ---- | ---- | 256.47%2.81M | -11,229.58%-7.9M | ---- |
| -Change in payables and accrued expense | ---- | ---- | ---- | -113.36%-6.09M | ---- | ---- | ---- | 143.75%10.91M | 589.18%45.61M | ---- |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --8.86M | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 335.48%13.65M | -43.72%18.29M | -94.46%2.24M | 139.85%54.65M | -224.92%-21.44M | 105.91%3.13M | 542.22%32.49M | 253.38%40.46M | -66.22%22.78M | -41.02%17.16M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -103.15%-4.3M | 91.01%-3.21M | -98.79%119K | 194.88%129.08M | 175.69%18.48M | 471.79%136.44M | -4,368.84%-35.71M | 113.30%9.86M | 30.06%-136.04M | 75.80%-24.42M |
| Capital expenditure reported | -289.40%-5.62M | 71.46%-2.44M | 64.43%-2.05M | ---- | ---- | 95.72%-1.44M | ---8.56M | ---5.77M | ---- | ---- |
| Net PPE purchase and sale | ---- | ---- | ---- | 88.14%-24.05M | ---- | ---- | 84.68%-8.56M | 92.93%-5.77M | 17.08%-202.81M | ---- |
| Net business purchase and sale | ---- | ---- | ---- | ---2.09M | ---- | ---- | ---- | ---- | --0 | ---- |
| Net investment purchase and sale | --0 | --0 | --0 | ---- | ---- | --0 | --0 | ---2.09M | ---- | ---- |
| Net other investing changes | -99.04%1.32M | 97.17%-768K | -87.75%2.17M | 132.46%155.22M | 269.25%26.76M | 4,691.61%137.89M | -149.33%-27.15M | 136.49%17.73M | -16.72%66.77M | 143.75%7.25M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -103.15%-4.3M | 91.01%-3.21M | -98.79%119K | 194.88%129.08M | 175.69%18.48M | 471.79%136.44M | -4,368.84%-35.71M | 113.30%9.86M | 30.06%-136.04M | 75.80%-24.42M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 94.69%-7.51M | -116.00%-15M | 94.04%-2.28M | -280.22%-183.79M | -57.57%3M | -1,143.75%-141.54M | -123.84%-6.94M | -173.32%-38.3M | -25.78%101.98M | -91.36%7.06M |
| Net issuance payments of debt | 95.06%-6.75M | -262.84%-8.73M | 97.77%-658K | -234.45%-157.88M | 2.00%10.79M | -873.97%-136.78M | -107.10%-2.41M | -153.36%-29.49M | -21.26%117.43M | -87.95%10.58M |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Interest paid (cash flow from financing activities) | 39.00%-3.59M | 53.18%-3.67M | 56.12%-3.87M | -80.22%-27.84M | -51.22%-5.32M | -42.92%-5.88M | -63.71%-7.84M | -190.47%-8.81M | -31.90%-15.45M | 41.69%-3.52M |
| Net other financing activities | 153.00%2.83M | -178.81%-2.6M | --2.24M | --1.94M | ---2.48M | --1.12M | --3.3M | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 94.69%-7.51M | -116.00%-15M | 94.04%-2.28M | -280.22%-183.79M | -57.57%3M | -1,143.75%-141.54M | -123.84%-6.94M | -173.32%-38.3M | -25.78%101.98M | -91.36%7.06M |
| Net cash flow | ||||||||||
| Beginning cash position | -89.75%202K | -98.99%123K | -58.10%44K | -99.08%105K | -98.31%5K | -91.00%1.97M | 1,191.37%12.13M | -99.08%105K | 1,013.41%11.38M | -78.58%296K |
| Current changes in cash | 193.59%1.84M | 100.78%79K | -99.34%79K | 99.46%-61K | 120.42%39K | 90.90%-1.97M | -148.42%-10.16M | 215.14%12.02M | -208.85%-11.27M | -101.91%-191K |
| End cash Position | 40,740.00%2.04M | -89.75%202K | -98.99%123K | -58.10%44K | -58.10%44K | -98.31%5K | -91.00%1.97M | 1,191.37%12.13M | -99.08%105K | -99.08%105K |
| Free cash from | 374.81%8.03M | -33.81%15.84M | -99.45%190K | 117.00%30.6M | -104.91%-29.71M | 105.26%1.69M | 137.89%23.94M | 149.43%34.69M | -1.63%-180.02M | 69.62%-14.5M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.